Abstract:Objective:To observe the curative effect, survival rate, enucleation rate and pathological characteristics of retinoblastoma (RB) in children.Methods:Retrospective clinical study. From March 1999 to December 2018, a total of 313 patients (445 eyes) with RB diagnosed in Ophthalmology Department of Peking University People’s Hospital were enrolled in the study. Among them, 175 were male (55.9%), 138 were female (44.1%); 181 were monocular and 132 were binocular. The international standard of intraocular RB staging (IIRC) was 6, 13, 6, 52, 227 and 9 patients of A, B, C, D, E and extraocular stages respectively. Among the 313 patients, 245 patients were confirmed to the survivance, of which 22 cases (9.0%, 22/245) died. Among 445 eyes, 330 eyes definitely whether or not were enucleated; 184 eyes had definite IIRC stage, eye examination results, definite treatment plan and times before enucleation and definite pathological tumor node metastasis stage after operation. The basic information, demographic characteristics, clinical information, enucleation and treatment plan, pathological and immunohistochemical results were recorded. Binary logistic regression was used to analyze the risk factors of high risk pathological features (HRF) and prognosis in patients with RB.Results:From 1999 to 2018, the survival rate of 245 patients was increased from 82.6% to 96.3% year by year; the enucleation rate of 330 eyes with final enucleation was reduced from68.8% to 58.3% year by year. The rate of enucleation in stage D and stage E decreased from 83.3% and 100% before 2005 to 37.5% and 85.4% after 2014, respectively. Monocular disease ( β=-1.551, P=0.005), stage D, stage E and extraocular stage in IIRC stage ( P<0.005) were the independent risk factors of RB enucleation, while the protective factors were Interventional chemotherapy of ophthalmic artery (IAC) ( β=-0.877, P<0.001). HRF was found in 51 eyes (27.7%). Age of onset ( β=0.019, P=0.016) and glaucoma ( β=0.816, P=0.050) were independent risk factors for HRF in RB pathology, while IAC treatment was the protective factor for enucleation ( β=21.432, P<0.001). Conclusions:After comprehensive treatment, the general trend of RB enucleation rate is gradually decreasing. IAC treatment can reduce the enucleation rate of stage D and E. The older age of onset and glaucoma stage are the independent risk factors of HRF, and IAC can reduce the risk factors of HRF.

Expression of Multidrug-Resistance Associated Proteins in Human Retinoblastoma Treated by Primary Enucleation

The role of PAX6 and its downstream gene on differentiation of human retinoblastoma cells

Expression Levels of Autophagy Related Proteins and Their Prognostic Significance in Retinocytoma and Retinoblastoma

Clinical treatment and prognostic observation for different pathological infiltrations in 537 patients with unilateral retinoblastoma.

[Clinicopathologic Features of Retinoblastoma and Expression of VEGF and Ki-67 after Comprehensive Treatment].

Expression of multidrug resistant gene and multidrug resistant associated protein in retinoblastoma

Expression Of Emmprin, Mmps And Timp2 In Retinoblastoma And Normal Retinal Tissue

Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway

Long Noncoding RNA TRPM2-AS Promotes the Growth, Migration, and Invasion of Retinoblastoma Via Mir-497/Wee1 Axis

Expression of the P53, Bcl - 2 and PCNA in Retinoblastoma

Expression and clinical significance of brain derived neurotrophic factor in retinoblastoma

Expression of DNA Methyltransferases 1,3a,and 3b in Retinoblastoma

Genetic characteristics and clinical screening and treatment of retinoblastoma

Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study

Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma

Heat shock proteins and survivin: relationship and effects on proliferation index of retinoblastoma cells.

Single-cell Characterization of Malignant Phenotypes and Microenvironment Alteration in Retinoblastoma.

Bioinformatics Analysis of Multi-Omics Data Identifying Molecular Biomarker Candidates and Epigenetically Regulatory Targets Associated with Retinoblastoma

Retrospective clinical study on the comprehensive treatment of retinoblastoma

Itraq-Based Quantitative Proteomic Analysis and Bioinformatics Study of Proteins in Retinoblastoma.

A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses